Read + Share
Jackson TL, Slakter J, Buyse M, Wang K, et al. A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular
age-related macular degeneration. Ophthalmology 2023 Feb 6:S0161-6420(23)00066.
PMID: 36754174
|
 |
|
Jackson TL, Slakter J, Buyse M, Wang K, et al. A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular
age-related macular degeneration. Ophthalmology 2023 Feb 6:S0161-6420(23)00066.
PMID: 36754174
|
|
|
|